Marquez-Megias, S., Ramon-Lopez, A., Mas-Serrano, P., Diaz-Gonzalez, M., Candela-Boix, M., & Nalda-Molina, R. (2021). Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients with Inflammatory Bowel Disease.
Citación estilo ChicagoMarquez-Megias, S., A. Ramon-Lopez, P. Mas-Serrano, M. Diaz-Gonzalez, MR Candela-Boix, y R. Nalda-Molina. Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients With Inflammatory Bowel Disease. 2021.
Cita MLAMarquez-Megias, S., et al. Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients With Inflammatory Bowel Disease. 2021.
Precaución: Estas citas no son 100% exactas.